Delivery Order SPE2DB20D3103-SPE2DB23FP9D8
Award Date
9/27/23
Potential Completion Date
9/28/23
Potential Value
$36K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $11,244.44 firm-fixed price delivery order is for the supply of ABRAXANE 100 MG VIALS, a pharmaceutical product. The contract has a completion date of July 12, 2024 and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,292.38, is for the delivery of ABRAXANE 100 MG VIALS, a specialty medication. The contract has an ultimate completion date of December 19, 2023 and is a firm fixed price delivery order. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for ABRAXANE 100 MG VIALS, a specialty pharmaceutical product. The contract is a firm fixed price delivery order with a potential value of $3,943.32 and a completion date of March 5, 2024. Amerisourcebergen Drug Corp has received numerous prior awards from...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,841.20 firm fixed-price delivery order is for 4560863156 ABRAXANE 100 MG VIALS, with a performance period through May 9, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,382.22, is for the delivery of ABRAXANE 100 MG VIALS, a specialty cancer medication. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a...
This federal contract award, with ID SPE2DB24D1205|SPE2DB25FCUWG, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,603.41 firm fixed-price delivery order is for the supply of ABRAXANE 100 MG VIALS, with a performance period through March 13, 2025. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $9,199.46 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide ABRAXANE 100 MG vials. The contract has a completion date of February 21, 2024. Amerisourcebergen Drug Corp holds several other indefinite delivery contracts with DLA and the Department of Justice Federal Bureau of Investigation Headquarters Division to supply pharmaceuticals and medical...
This contract award is for the delivery of ABRAXANE 100 MG VIALS to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, with a ceiling value of $65,778.16. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $16,462.22 firm fixed-price contract is for the supply of a pharmaceutical product, ABRYSVO VIAL WITH DILUENTS, with a completion date of April 19, 2024. Amerisourcebergen, a major pharmaceutical distribution company, is delivering this product under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $10,400.74 and will run through December 27, 2024. The contract provides for the delivery of ABRYSVO VIAL WITH DILUENT SYRGS, a medical product, to support federal healthcare programs. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...